Unnatural Products
Pioneering the development of synthetic macrocyclic peptides
Santa Cruz, United States · Founded 2016 · $83.0M raised
- Headquarters
- Santa Cruz, California
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- unnaturalproducts.com
- Total Funding
- $83.0M
- Last Round
- $45.0M Series BMar 2026
- Rounds
- 3
About
Unnatural Products is a Santa Cruz-based biotech pioneering synthetic macrocyclic peptides as orally-delivered drug therapies for challenging diseases. The company's scalable platform enables rapid optimization of potency, selectivity, and permeability.
Summary
Unnatural Products is a Biotech company based in Santa Cruz, United States, founded in 2016. It has raised $83.0M in total across 3 rounds, most recently a $45.0M Series B round in Mar 2026. Investors include Artis Ventures (AV), The Venture Collective and Merck Global Health Innovation Fund.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Artis Ventures (AV)
3 rounds
The Venture Collective
2 rounds
Merck Global Health Innovation Fund
2 rounds
First Spark Ventures
2 rounds
Droia Ventures
1 round
HUMAIN
1 round
LongeVC
1 round
Not Boring Capital
1 round
Abstract Ventures
1 round
Asset Management Ventures
1 round
better ventures
1 round
Blue Bear Capital
1 round
Rising Tide
1 round
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.